Swiss National Bank Axogen, Inc. Call Options Transaction History
Swiss National Bank
- $137 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AXGN
# of Institutions
191Shares Held
39.2MCall Options Held
61.7KPut Options Held
42.8K-
First Light Asset Management, LLC Edina, MN4.47MShares$50.2 Million10.62% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$36.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.6MShares$29.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$28.5 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO1.59MShares$17.9 Million0.54% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $475M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...